Patent ID: 7417142

Claim:
A chiral porphyrin compound having the structure of Formula (I): wherein: M is present or absent and when present is H 2 or a transition metal; R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are each independently selected from the group consisting of a heteroatom-containing chiral moiety, H, alkyl, substituted alkyl, arylalkyl, aryl, and substituted aryl; and at least one of R 1 , R 2 , R 3 , R 4 , R 5 and R 6 is a heteroatom-containing chiral moiety selected from the group consisting of (+)-estrone, (+)-dihydrocholesterol, R-(+)-1,1 ′-bi-2-naphthol, (R)-(+)-4-benzyl-2-oxazolidinone, (L)-phenylalanine methyl ester, 1-[1′-(R)-α-methylbenzyl]-aziridine-2(R)-carboxamide, (R)-(−)-2-methoxypropionamide, (S)-(+)-2-methoxypropionamide, (S)-(+)-2,2-dimethylcyclopropanecarboxamide, and L-(R)-lactamide; or at least one of R 1 and R 6 is a group having the structure: wherein: R 11 is selected from the group consisting of H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, arylalkyl, aryl, and substituted aryl and wherein Y is selected from the group consisting of (+)-estrone, (+)-dihydrocholesterol, R-(+)-1,1′-bi-2-naphthol, (R)-(+)-4-benzyl-2-oxazolidinone, (L)-phenylalanine methyl ester, 1-[1′-(R)-α-methylbenzyl]-aziridine-2(R)-carboxamide, (R)-(−)-2-methoxypropionamide, (S)-(+)-2,2-dimethylcyclopropanecarboxamide, and L-(R)-lactamide.